KRKA tovarna zdravil d.d. Novo mesto
- Address
- Smarjeska Cesta 6
Sponsor Overview
Specializations
Arterial Hypertension
Research activity in arterial hypertension centers on blood pressure control with single-pill combinations containing telmisartan, amlodipine, and hydrochlorothiazide. The clinical focus includes sustained 24-hour pressure reduction and office blood pressure management in adults with grade 1, grade 2, and grade 3 hypertension.
- Telmisartan/amlodipine
- Telmisartan/amlodipine/hydrochlorothiazide
- 24-hour blood pressure reduction
- Blood pressure variability
The therapeutic interest extends to combination treatment strategies used in cardiovascular risk management.
Hyperlipidaemia
Studies in hyperlipidaemia examine LDL cholesterol lowering in patients with high or very high cardiovascular risk. The research includes rosuvastatin and rosuvastatin/ezetimibe combinations, with attention to achieving guideline-based lipid targets.
- Rosuvastatin
- Rosuvastatin/ezetimibe
- LDL-C goal achievement
- Cardiovascular risk reduction
The lipid-focused portfolio reflects interest in therapies for patients requiring intensive cholesterol management.
Knee Osteoarthritis
Research in knee osteoarthritis addresses pain-related and inflammatory aspects of the condition, with attention to synovial fluid biomarkers such as interleukin-6. The therapeutic area includes naproxen sodium and its effects on joint inflammation and clinical symptoms.
- Naproxen sodium
- Synovial fluid cytokines
- Interleukin-6
- Clinical outcomes in osteoarthritis
This area combines interest in musculoskeletal pain with inflammatory mechanisms relevant to joint disease.
Cardiovascular and Metabolic Therapy
The sponsor’s clinical research landscape is strongly oriented toward cardiovascular medicine and metabolic disease management, particularly therapies used to control blood pressure and lipid disorders. These areas reflect a focus on chronic conditions that require long-term pharmacological treatment.
- Antihypertensive combinations
- Lipid-lowering therapy
- Cardiovascular disease risk
- Chronic disease management
The funded trials also involve multicentre collaboration across several countries and research sites in Europe.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety of Rosuvastatin and Rosuvastatin/Ezetimibe Combination in High-Risk Hyperlipidemia Patients: A 12-Week Randomized Trial |  Croatia Germany Hungary Poland Slovenia | Not Recruiting |
| Evaluation of Naproxen Sodium on Synovial Fluid Cytokine Levels and Clinical Outcomes in Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial | Poland | Not Recruiting |
| Evaluation of Telmisartan/Amlodipine and Telmisartan/Amlodipine/Hydrochlorothiazide on 24-Hour Blood Pressure Control in Arterial Hypertension Patients | Hungary Poland Slovenia | Not Recruiting |
Data & Insights
This sponsor works with 7 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 31 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases2 trials359 other sponsors
- 2.Musculoskeletal Diseases1 trial238 other sponsors
Partnered Research Centres
31 centres- Address
- Ulica dr. Hrovata 4, 2270 Ormoz
- Address
- Ul. Marii Opielinskiej 16b, 25-426 Kielce
- Address
- Gyogy Ter 2, 8230 Balatonfured
- Address
- Semmelweis Utca 1, 5700 Gyula
- Address
- Tancsics Mihaly Utca 1, 2051 Biatorbagy
- Address
- Schlossstrasse 12, Marienthal, 22041 Hamburg
Want to get in touch with this sponsor?
Send a question and we'll pass it on to KRKA tovarna zdravil d.d. Novo mesto.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.